AAAAAA
Results: 1-25/363
Authors:
BRODATY H
CLARKE J
GANGULI M
GREK A
JORM AF
KHACHATURIAN Z
SCHERR P
Citation: H. Brodaty et al., SCREENING FOR COGNITIVE IMPAIRMENT IN GENERAL-PRACTICE - TOWARD A CONSENSUS, Alzheimer disease and associated disorders, 12(1), 1998, pp. 1-13
Authors:
FASTBOM J
FORSELL Y
WINBLAD B
Citation: J. Fastbom et al., BENZODIAZEPINES MAY HAVE PROTECTIVE EFFECTS AGAINST ALZHEIMER-DISEASE, Alzheimer disease and associated disorders, 12(1), 1998, pp. 14-17
Authors:
JOHNSON DL
SMITH SD
Citation: Dl. Johnson et Sd. Smith, EFFECTS OF FAMILIARITY AND TEMPORAL ORGANIZATION ON MEMORY FOR EVENT SCHEMAS IN AGED AND ALZHEIMER SUBJECTS - IMPLICATIONS FOR CLINICAL MANAGEMENT, Alzheimer disease and associated disorders, 12(1), 1998, pp. 18-25
Authors:
DEDEYN PP
HIRAMATSU M
BORGGREVE F
GOEMAN J
DHOOGE R
SAERENS J
MORI A
Citation: Pp. Dedeyn et al., SUPEROXIDE-DISMUTASE ACTIVITY IN CEREBROSPINAL-FLUID OF PATIENTS WITHDEMENTIA AND SOME OTHER NEUROLOGICAL DISORDERS, Alzheimer disease and associated disorders, 12(1), 1998, pp. 26-32
Authors:
WARZOK RW
KESSLER C
APEL G
SCHWARZ A
EGENSPERGER R
SCHREIBER D
HERBST EW
WOLF E
WALTHER R
WALKER LC
Citation: Rw. Warzok et al., APOLIPOPROTEIN E4 PROMOTES INCIPIENT ALZHEIMER PATHOLOGY IN THE ELDERLY, Alzheimer disease and associated disorders, 12(1), 1998, pp. 33-39
Authors:
BREITNER JCS
JARVIK GP
PLASSMAN BL
SAUNDERS AM
WELSH KA
Citation: Jcs. Breitner et al., RISK OF ALZHEIMER-DISEASE WITH THE EPSILON-4 ALLELE FOR APOLIPOPROTEIN-E IN A POPULATION-BASED STUDY OF MEN AGED 62-73 YEARS, Alzheimer disease and associated disorders, 12(1), 1998, pp. 40-44
APOLIPOPROTEIN E4 IN PARKINSON-DISEASE AND DEMENTIA - NEW DATA AND METAANALYSIS OF PUBLISHED STUDIES
Authors:
INZELBERG R
CHAPMAN J
TREVES TA
ASHEROV A
KIPERVASSER S
HILKEWICZ O
VERCHOVSKY R
KLIMOWITZKY S
KORCZYN AD
Citation: R. Inzelberg et al., APOLIPOPROTEIN E4 IN PARKINSON-DISEASE AND DEMENTIA - NEW DATA AND METAANALYSIS OF PUBLISHED STUDIES, Alzheimer disease and associated disorders, 12(1), 1998, pp. 45-48
Authors:
JULIN P
ALMKVIST O
BASUN H
LANNFELT L
SVENSSON L
WINBLAD B
WAHLUND LO
Citation: P. Julin et al., BRAIN VOLUMES AND REGIONAL CEREBRAL BLOOD-FLOW IN CARRIERS OF THE SWEDISH ALZHEIMER AMYLOID PROTEIN MUTATION, Alzheimer disease and associated disorders, 12(1), 1998, pp. 49-53
Authors:
BECKER RE
COLLIVER JA
MARKWELL SJ
MORIEARTY PL
UNNI LK
VICARI S
Citation: Re. Becker et al., EFFECTS OF METRIFONATE ON COGNITIVE DECLINE IN ALZHEIMER-DISEASE - A DOUBLE-BLIND, PLACEBO-CONTROLLED, 6-MONTH STUDY, Alzheimer disease and associated disorders, 12(1), 1998, pp. 54-57
Authors:
WHITEHOUSE P
MASLOW K
Citation: P. Whitehouse et K. Maslow, DEFINING AND MEASURING OUTCOMES IN ALZHEIMER-DISEASE RESEARCH - INTRODUCTION AND OVERVIEW, Alzheimer disease and associated disorders, 11, 1997, pp. 1-6
Authors:
CLANCY CM
COOPER JK
Citation: Cm. Clancy et Jk. Cooper, OUTCOMES AND EFFECTIVENESS RESEARCH IN ALZHEIMER-DISEASE, Alzheimer disease and associated disorders, 11, 1997, pp. 7-11
Authors:
KANE RL
Citation: Rl. Kane, WHICH OUTCOMES MATTER IN ALZHEIMER-DISEASE AND WHO SHOULD DEFINE THEM, Alzheimer disease and associated disorders, 11, 1997, pp. 12-17
Authors:
GWYTHER LP
Citation: Lp. Gwyther, THE PERSPECTIVE OF THE PERSON WITH ALZHEIMER-DISEASE - WHICH OUTCOMESMATTER IN EARLY TO MIDDLE STAGES OF DEMENTIA, Alzheimer disease and associated disorders, 11, 1997, pp. 18-24
Authors:
TENO JM
LANDRUM K
LYNN J
Citation: Jm. Teno et al., DEFINING AND MEASURING OUTCOMES IN END-STAGE DEMENTIA, Alzheimer disease and associated disorders, 11, 1997, pp. 25-29
Authors:
SMYTH KA
FERRIS SH
FOX P
HEYMAN A
HOLMES D
MORRIS JN
PHILLIPS CD
SCHULZ R
TERESI J
WHITEHOUSE PJ
Citation: Ka. Smyth et al., MEASUREMENT CHOICES IN MULTISITE STUDIES OF OUTCOMES IN DEMENTIA, Alzheimer disease and associated disorders, 11, 1997, pp. 30-44
Authors:
FERRIS SH
KLUGER A
Citation: Sh. Ferris et A. Kluger, ASSESSING COGNITION IN ALZHEIMER-DISEASE RESEARCH, Alzheimer disease and associated disorders, 11, 1997, pp. 45-49
Authors:
TERI L
LOGSDON R
YESAVAGE J
Citation: L. Teri et al., MEASURING BEHAVIOR, MOOD, AND PSYCHIATRIC-SYMPTOMS IN ALZHEIMER-DISEASE, Alzheimer disease and associated disorders, 11, 1997, pp. 50-59
Authors:
VOLICER L
HURLEY AC
Citation: L. Volicer et Ac. Hurley, PHYSICAL STATUS AND COMPLICATIONS IN PATIENTS WITH ALZHEIMER-DISEASE - IMPLICATIONS FOR OUTCOME STUDIES, Alzheimer disease and associated disorders, 11, 1997, pp. 60-65
Authors:
WARSHAW G
Citation: G. Warshaw, ASSESSING PHYSICAL STATUS IN ALZHEIMER-DISEASE RESEARCH, Alzheimer disease and associated disorders, 11, 1997, pp. 66-72
Authors:
BECK CK
FRANK LB
Citation: Ck. Beck et Lb. Frank, ASSESSING FUNCTIONING AND SELF-CARE ABILITIES IN ALZHEIMER-DISEASE RESEARCH, Alzheimer disease and associated disorders, 11, 1997, pp. 73-80
Authors:
SPECTOR WD
Citation: Wd. Spector, MEASURING FUNCTIONING IN DAILY ACTIVITIES FOR PERSONS WITH DEMENTIA, Alzheimer disease and associated disorders, 11, 1997, pp. 81-90
Authors:
LAWTON MP
Citation: Mp. Lawton, ASSESSING QUALITY-OF-LIFE IN ALZHEIMER-DISEASE RESEARCH, Alzheimer disease and associated disorders, 11, 1997, pp. 91-99
Authors:
RABINS PV
KASPER JD
Citation: Pv. Rabins et Jd. Kasper, MEASURING QUALITY-OF-LIFE IN DEMENTIA - CONCEPTUAL AND PRACTICAL ISSUES, Alzheimer disease and associated disorders, 11, 1997, pp. 100-104
Authors:
BUCKWALTER KC
MAAS M
REED D
Citation: Kc. Buckwalter et al., ASSESSING FAMILY AND STAFF CAREGIVER OUTCOMES IN ALZHEIMER-DISEASE RESEARCH, Alzheimer disease and associated disorders, 11, 1997, pp. 105-116
Authors:
SCHULZ R
WILLIAMSON GM
Citation: R. Schulz et Gm. Williamson, THE MEASUREMENT OF CAREGIVER OUTCOMES IN ALZHEIMER-DISEASE RESEARCH, Alzheimer disease and associated disorders, 11, 1997, pp. 117-124